These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34347332)

  • 41. Changes in the unregulated opioid drug supply during income assistance payment weeks in Vancouver, Canada: An exploratory analysis.
    Beaulac M; Richardson L; Tobias S; Lysyshyn M; Grant C; Ti L
    Int J Drug Policy; 2022 Jul; 105():103707. PubMed ID: 35504093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementing an integrated multi-technology platform for drug checking: Social, scientific, and technological considerations.
    Wallace B; Hills R; Rothwell J; Kumar D; Garber I; van Roode T; Larnder A; Pagan F; Aasen J; Weatherston J; Gozdzialski L; Ramsay M; Burek P; Azam MS; Pauly B; Storey MA; Hore D
    Drug Test Anal; 2021 Apr; 13(4):734-746. PubMed ID: 33646611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.
    Dasgupta N; Figgatt MC
    Am J Epidemiol; 2022 Jan; 191(2):248-252. PubMed ID: 34528056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An individual-based dynamic model to assess interventions to mitigate opioid overdose risk.
    Gallant K; Lukeman R
    Harm Reduct J; 2024 Aug; 21(1):146. PubMed ID: 39135022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of Fentanyl Analogs and Synthetic Opioids in Real Hair Samples.
    Salomone A; Palamar JJ; Bigiarini R; Gerace E; Di Corcia D; Vincenti M
    J Anal Toxicol; 2019 May; 43(4):259-265. PubMed ID: 30462247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
    Boyd J; Collins AB; Mayer S; Maher L; Kerr T; McNeil R
    Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
    Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
    Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "We don't got that kind of time, man. We're trying to get high!": Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs.
    Bardwell G; Boyd J; Tupper KW; Kerr T
    Int J Drug Policy; 2019 Sep; 71():125-132. PubMed ID: 31336258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.
    Olding M; Ivsins A; Mayer S; Betsos A; Boyd J; Sutherland C; Culbertson C; Kerr T; McNeil R
    Am J Public Health; 2020 Jun; 110(6):833-835. PubMed ID: 32298171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.
    Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S
    Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with drug checking service utilization among people who use drugs in a Canadian setting.
    Long V; Arredondo J; Ti L; Grant C; DeBeck K; Milloy MJ; Lysyshyn M; Wood E; Kerr T; Hayashi K
    Harm Reduct J; 2020 Dec; 17(1):100. PubMed ID: 33317553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
    Gozdzialski L; Wallace B; Hore D
    Harm Reduct J; 2023 Mar; 20(1):39. PubMed ID: 36966319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope / fentanyl toxicity cases in Alberta, Canada.
    Chatterton CN; Handy RP
    Forensic Sci Int; 2023 Sep; 350():111777. PubMed ID: 37478730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-Series Analysis of Fentanyl Concentration in the Unregulated Opioid Drug Supply in a Canadian Setting.
    Tobias S; Grant CJ; Laing R; Arredondo J; Lysyshyn M; Buxton J; Tupper KW; Wood E; Ti L
    Am J Epidemiol; 2022 Jan; 191(2):241-247. PubMed ID: 33977304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.